1 Inhibits Gene
| WormBase Gene ID | Gene Name | Sequence Name | Organism |
|---|---|---|---|
| WBGene00004161 | pqn-80 | Y111B2A.14 | Caenorhabditis elegans |
15 Inhibits Predicted Gene
| WormMine ID | Sequence Name | Length (nt) | Chromosome Location |
|---|---|---|---|
| CDS:Y111B2A.14a | Y111B2A.14a |
4251
 |
III: 12626575-12626718 |
| CDS:Y111B2A.14b | Y111B2A.14b |
4341
|
III: 12626575-12626718 |
| CDS:Y111B2A.14f | Y111B2A.14f |
3681
|
III: 12628947-12629306 |
| CDS:Y111B2A.14g | Y111B2A.14g |
3762
|
III: 12628947-12629306 |
| CDS:Y111B2A.14h | Y111B2A.14h |
3672
|
III: 12628947-12629306 |
| CDS:Y111B2A.14k | Y111B2A.14k |
3192
|
III: 12630583-12630678 |
| CDS:Y111B2A.14m | Y111B2A.14m |
1773
|
III: 12641850-12642314 |
| CDS:Y111B2A.14o | Y111B2A.14o |
1164
|
III: 12644525-12644596 |
| CDS:Y111B2A.14c | Y111B2A.14c |
4350
|
III: 12626575-12626718 |
| CDS:Y111B2A.14d | Y111B2A.14d |
4260
|
III: 12626575-12626718 |
| CDS:Y111B2A.14e | Y111B2A.14e |
3771
|
III: 12628947-12629306 |
| CDS:Y111B2A.14i | Y111B2A.14i |
3201
|
III: 12630583-12630678 |
| CDS:Y111B2A.14j | Y111B2A.14j |
3111
|
III: 12630583-12630678 |
| CDS:Y111B2A.14l | Y111B2A.14l |
3102
|
III: 12630583-12630678 |
| CDS:Y111B2A.14n | Y111B2A.14n |
1683
|
III: 12641850-12642314 |
5 Phenotype _ Not _ Observed
| Identifier | Name | Description |
|---|---|---|
| WBPhenotype:0000886 | nematode phenotype | Animals exhibit variations compared to a given control. |
| WBPhenotype:0000050 | embryonic lethal | Animals die during embryonic development. In C. elegans, often assayed as refractile eggs that fail to hatch; when applied to large-scale RNAi screens in C. elegans, more than 10% of embryos die. |
| WBPhenotype:0000062 | lethal | Animals die prematurely at any stage of the life cycle. |
| WBPhenotype:0000535 | organism morphology variant | Animals exhibit variations in the form, structure or composition of any part of their anatomy compared to control animals. |
| WBPhenotype:0000689 | maternal sterile | Animals produce no or very few embryos as a result of experimental treatment. This is in contrast to sterility due to genetic perturbations (maternal effect sterility). |
